Anavex is going after CNS conditions which are all linked.
They are not going after too many indications that have nothing to do with each other.
If they were doing kidney issues, heart issues, COVID, and CNS.
Maybe you would be correct on your statements.
Unfortunately they understand that these CNS are linked together and if their drug works well up stream they can treat them all.
If this is too complicated for you maybe this company is not for you.
I been told to never invest in anything I do not understand well.
Even then there is lots of risk, unknown-unknowns.
Market Data 
Markets 
AI
